BGI Genomics Co., Ltd.

300676

CNE100003449

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 2025-01-20			5-day change	1st Jan Change
39.16 ^CNY	-0.03%		+0.46%	-6.70%

Oct. 25	BGI Genomics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
Sep. 13	BGI Genomics Gets Registration for Expanded Use of Hereditary Deafness Gene Detection Kit	MT

BGI Genomics Gets Registration for Expanded Use of Hereditary Deafness Gene Detection Kit

September 13, 2024 at 12:43 am EDT

This article is reserved for members

Already a member?

Not a member ?

Free registration

Latest news about BGI Genomics Co., Ltd.

BGI Genomics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	24-10-25	CI
BGI Genomics Gets Registration for Expanded Use of Hereditary Deafness Gene Detection Kit	24-09-13	MT
US Biosecure Act Could Boost South Korean Biotech Companies, Report Says	24-09-11	MT
BGI Genomics to Inject 149 Million Yuan in Equity Investment Fund	24-09-11	MT
China slams US bill targeting biotech firms as 'discriminatory'	24-09-10	RE
US Democrat Congressman to Block Bill Banning Business with Chinese Biotech Firms	24-09-09	MT
BGI Genomics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	24-08-23	CI
BGI Genomics Announces the Opening of the Astana Genetic Center in Astana, Kazakhstan in Partnership with Technopark Biogen	24-07-25	CI
BGI Genomics Opens Lab in Kazakhstan	24-07-23	MT
BGI Genomics Co., Ltd. Announces Board Appointments	24-06-19	CI
US Legislation Banning Chinese Biotech Firms Will Suppress Legislation, BGI Says	24-05-20	MT
BGI Genomics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	24-04-26	CI
BGI Genomics' 2023 Profit Falls 89% as Revenue Plunges 38%	24-02-29	MT
BGI Genomics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	24-02-29	CI
China stocks rise further on market rescue hopes; HK flat	24-02-06	RE
Wuxi AppTec Denies Ties to Military in Wake of US Draft Bill Targeting Chinese Biotech Firms	24-02-05	MT
US bill targeting Chinese biotech firms WuXi AppTec, BGI hits delay	24-02-02	RE
Correction: GemPharmatech Responds to US Legislation Concerns	24-01-29	MT
Correction: Chinese Shares End Lower on US Draft Bill Targeting Chinese Biotech Firms; MGI Slumps 12%, Wuxi AppTec Falls 9%	24-01-29	MT
GemPharmatech Responds to US Legislation Concerns	24-01-29	MT
MGI Tech Responds to US BIOSECURE Act	24-01-29	MT
Chinese Shares End Lower on US Draft Bill Targeting Chinese Biotech Firms; MGI Slumps 12%, Wuxi AppTec Falls 9%	24-01-29	MT
US House bill would curb genetic info sharing with China's Wuxi Apptec, BGI	24-01-26	RE
BGI Genomics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Chinese Shares Extend Losses as Bank Borrowing Plunges to 14-Year Low; BGI Falls 6% After M&A Announcement	23-08-14	MT

BGI Genomics Co., Ltd. is a leading provider of genomic and proteomic sequencing services primarily to academic institutions, pharmaceutical companies and healthcare providers. The company also provides genomic solutions for biomarker research and development, screening for some of the trisomies present at birth (trisomy 21, trisomy 18 and trisomy 13) and solutions for neo-antigen identification for immuno-oncology research.

Employees

Sector

Biotechnology & Medical Research

Calendar

2025-04-23 - Q4 2024 Earnings Release (Projected)

More about the company